As part of the Startup SG Equity scheme, the government will co-invest with independent, qualified 3rd party investors into eligible startups. This scheme aims to stimulate private-sector investments into innovative, Singapore-based technology startups with intellectual property and global market potential.
SPRING Seeds Capital Pte Ltd (SSC) and SGInnovate have been appointed to manage the funds under Startup SG Equity.
Startup SG Equity has different investment parameters for general tech and deep tech startups:
|General tech||Deep tech|
|Investment Cap for each startup||$2M||$4M|
|Co-investment ratio||7:3 up to $250K,
1:1 thereafter up to $2M
|7:3 up to $500K,
1:1 thereafter up to $4M
Startups and investors may apply for Startup SG Equity. Each category has its own set of eligibility criteria.
Eligibility for startups:
Startups seeking government co-investment under Startup SG Equity should meet the following criteria:
- Be a Singapore-based company with core activities carried out here.
- Be incorporated as a Private Limited company for less than five years.
- Have paid-up capital of at least $50,000.
- Be able to prove substantial innovative and intellectual content for its products and/or services and applications.
- Have high-growth potential with clear scalability for the international market.
- Have identified a ready, independent third-party investor(s).
- Business must not be involved in the following business activities: gambling, tobacco-related products, or any other activities which are in violation of law, or against public interest.
- Company cannot be a subsidiary or joint-venture.
Eligibility for third-party investors:
To be eligible for co-investment, interested individuals or corporate investors should meet the following criteria:
- The investor(s) must be able to contribute to the startup’s growth. The investor(s) should possess the management experience, relevant business contacts and/or necessary technical expertise that can value-add to the startup.
- The investor(s) must be prepared to invest at least $50,000 each into each startup.
- The investor(s) should not hold shares in the investee prior to the co-investment (for new investments).
About SPRING SEEDS Capital
SPRING SEEDS Capital (SSC), an investment arm of SPRING Singapore, stimulates smart investments into innovative Singapore-based startups with strong intellectual content and global market potential. Through co-investments, SSC aims to catalyse investments into new, underserved but strategic sectors, in particular Advanced Manufacturing & Engineering, Health & Biomedical Sciences, and Urban Sustainability & Solutions. We also invest in emerging technologies such as Fintech, Artificial Intelligence, and Agritech. As part of SPRING Singapore, we help our startups commercialize and expand globally, leveraging as well on the expertise and strategic networks of our co-investment partners in areas such as technology translation, commercialization and market expansion.
At SGInnovate, we believe that Singapore has all the resources and capabilities needed to tackle ‘hard problems’ that matter to people around the world. As a part of the robust startup ecosystem here, our mission is to enable ambitious and capable individuals and teams to imagine, start, build, and scale globally-relevant technologies. With the support of our partners, SGinnovate’s priority is to work with deeply-technical founders that have research-originated IP at the core of their company. We back these entrepreneurs through equity-based investments, access to talent, and support in building customer traction. We are prioritising our efforts around Artificial Intelligence, Robotics and Blockchain. These technologies represent impactful and scalable answers to global challenges. SGInnovate is a private-limited company wholly owned by the Singapore Government.
Applicants must submit a two-page executive summary and supporting documents of the business for a first-level assessment. These documents may include:
- Business plan
- Financial statements or management accounts
- Business ACRA
- Background of potential co-investor (if available)
You may also download the Startup SG Equity FAQs.
The following partners are appointed partners under Startup SG Equity.
For partners that focus on Advanced Manufacturing & Engineering, Health & Biomedical Sciences and Urban Solutions & Sustainability, the co-investment partner under Startup SG Equity is SPRING SEEDS Capital (SSC) .
For partners that focus on Services & Digital Economy, the co-investment partner under Startup SG Equity is SGInnovate.
|Name of Appointed Partner||Investment Stage||Sectors of Focus||Contact Information|
|1||Armstrong Industrial Corporation||Seed to Series A||Advanced Manufacturing & Engineering; Health & Biomedical Sciences||Contact Person(s): Phyllis Ong; Kenneth Ling|
Email: firstname.lastname@example.org; email@example.com
|2||C31 Ventures||Series A to C||Services & Digital Economy||Contact Person: Ervin Lim|
Contact Number: 6713 2888
|3||Clearbridge BSA||Seed to Series A||Health & Biomedical Sciences||Contact Person: Johnson Chen|
|4||Cocoon Capital||Seed||Services & Digital Economy||Contact Person: Michael Blakey|
|5||Decacorn Partners||Seed to Series A/B||Services & Digital Economy|| Contact Person: Abhijit Banerjee|
Contact Number: 9839 1480
|6||Dymon Asia Ventures||Seed to Series B||Services & Digital Economy||Contact Person: Jennifer Ho|
Contact Number: 6705 1666
|7||Gobi Partners||Seed to Growth Stage||Services & Digital Economy||Contact Person: Teng Teng Lee|
Contact Number: 6640 3986
|8||Green Meadows Accelerator||Seed to Series A||Advanced Manufacturing & Engineering; Urban Solutions & Sustainability||Contact Person: Margaret Ong|
Tel : 8157 8515
|9||HealthXCapital||Seed to Series A||Health & Biomedical Sciences||Contact Person: Seemant Jauhari|
|10||Heritas Capital Management||Early to Late Stage||Health & Biomedical Sciences||Contact Person: Chik Wai Chiew|
Contact Number: 6716 0500
|11||Incuvest-Avior||Seed to Series A||Advanced Manufacturing & Engineering||Contact Person: Bernard Shum; Rachel Lei|
Email: firstname.lastname@example.org; email@example.com
|12||Jungle Ventures||Series A to B||Services & Digital Economy||Contact Person: Yashaswi Sankrityayan|
|13||Jungle Ventures (IOTPlus)||Seed to Series A||Advanced Manufacturing & Engineering||Contact Person: Chirayu Wadke|
|14||Med-Tech Alliance||Seed to Series A||Health & Biomedical Sciences||Email: firstname.lastname@example.org|
|15||Millennia-VFT Ventures||Seed to Series A||Urban Solutions & Sustainability||Contact Person(s): Seah Kiat Seng; Liaw Kok Eng|
Email: email@example.com; firstname.lastname@example.org
|16||Mojo Partners||Early to Late Stage||Services & Digital Economy||Contact Person: Damien Lim|
Contact Number: 6731 5975
|17||Monk’s Hill Ventures||Series A to B||Services & Digital Economy||Contact Person: Chow Yee Hoong|
Contact Number: 6514 0015
|18||MTA2||Seed to Series A||Advanced Manufacturing & Engineering; Health & Biomedical Sciences||Contact Person: Lee Wei Kang, Andrew Kwa, Samuel Chen|
Email: email@example.com; firstname.lastname@example.org; email@example.com
Website: www.accuronmedtech.com; www.edis.sg
|19||NSI Ventures||Series A||Services & Digital Economy||Contact Person: Ian Sikora|
Contact Number: 9656 4516
|20||Pix Vine Capital||Seed to Series A||Services & Digital Economy||Contact Person: Chou Fang Soong|
Contact Number: 6559 4670
|21||Qualgro Partners||Series A to B||Services & Digital Economy||Contact Person: Jason Edwards; Claire Ong|
Email: firstname.lastname@example.org; email@example.com
|22||Silicon Solution Partners||Seed to Series A||Advanced Manufacturing & Engineering||Contact Person: David Ng|
|23||Small World Accelerator||Seed to Series A||Advanced Manufacturing & Engineering; Urban Solutions & Sustainability||Contact Person: Frank H. Levinson; Chong Chiet Ping|
Email: firstname.lastname@example.org; email@example.com
|24||Supply Chain Angels||Seed to Series A||Services & Digital Economy||Contact Person: James Ong|
Contact Number: 6417 2608
|25||TNB-SPRING||Seed to Series A||Advanced Manufacturing & Engineering||Contact Person: Vicknesh R Pillay|
Tel: 6438 5616
|26||TNF Ventures||Seed and Pre-Series A||Services & Digital Economy||Contact Person: Frank Lee|
Contact Number: 6777 7022
|27||Trendlines Medical-K2 Global||Early to Late Stage||Health & Biomedical Sciences||Contact Person: Eric Loh; Ozi Amanat|
Email: firstname.lastname@example.org; email@example.com
Website: www.trendlines.com; k2globalvc.com
|28||TRIREC||Seed to Series A||Urban Solutions & Sustainability||Contact Person: Melvyn Yeo|
Tel: 6235 3738
|29||tryb Group||Seed, Venture Building and Late Stage||Services & Digital Economy||Contact Person: Michelle Huang|
Contact Number: 9817 3805
|30||ACP (previously known as Velocity)||Pre-Series AA to Series B||Services & Digital Economy||Contact Person: Shobhit Agrawal|
Contact Number: 8540 7392
|31||Venturecraft Group||Early to Late Stage||Health & Biomedical Sciences||Contact Person: Isaac Ho; Ong Jeong Shing|
Email: firstname.lastname@example.org; email@example.com
|32||Vickers Venture Partners||Seed to Series B||Services & Digital Economy||Contact Person: Terence Sim|
Contact Number: 6717 6666
|33||Wavemaker Partners||Seed to Series A||Advanced Manufacturing & Engineering; Services and Digital Economy||
For AME-related queries|
Contact Person: Gavin Lee
For SDE-related queries
|34||Zicom MedTacc||Seed to Series A||Health & Biomedical Sciences||Contact Person: Sim Kok Hwee|